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1. Introduction 
All cellular eukaryotic mRNAs studied so far 
contain at their 5’-terminus a blocked methylatcd 
structure often referred to as a ‘cap’. Most of the 
eukaryotic viral mRNAs are similarly modified. The 
general formula for the capped 5’-terminus of mRNAs 
may be represented as m7G(5’)ppp(5’)X(m)pY(mI. In
this structure the 7-methylguanosine (m”G) and the 
penultimate nucleoside (X) are joined by their 
.5’-hydroxyl groups through a triphosphate bridge. 
Nucfeosides X and Y are often also methyfated in the 
2’Oposition and an ~‘,2’~~imethyladenosine may 
be found in position X. The 26 S mRNA coded 
in vivo by Sindbis virus contains, in addition to the 
usual m7G, also mz2”G or m32s2J7G at its 5’-terminus 
PI f 
This article is concerned with the possible role 
played by the 5’-terminal cap in eukaryotic mRNA. 
For more details on the cap structure, its occurrence 
in different mRNA species, the mechanism of cap 
synthesis and earlier studies on its function, the 
reader is referred to the review by Shatkin [3] a 
Based on extensive in vitro translation studies two 
main functions have emerged for the .S’-terminal 
abbreviations: m7&, 7-methylguanosine; pm7G, 7-methyl- 
~anos~~5’-monophosphate; N, nucleoside (A,G,U or C); 
Nm, 2’-O-methyinucIeoside;AdoMet,S-adenosyl-methionine; 
AdoHcy, S-adenosyl-homocysteine; STNV, Satellite Tobacco 
Necrosis Virus; VW, Vesicular Stomatitis Virus; TMV, 
Tobacco Mosaic Virus; CPV, Cytoplasmic Palyhedrosis Virus 
rn7G~~N[~~- and GpppN-term~ated mRNA molecules are 
referred to as capped and blocked mRNAs, respectively. 
Nomencia~r~ used for the eukaryotic initiation factors is as 
in [II 
7-m~tbylguanosine. One is a facilitation ofmRNA 
entry into the initiation complex with eukaryotic 
ribosome, the second, a protection of mRNA against 
degradation by celluIar nucleases. 
2. Preparation of mRNA molecules with different 
S-termini 
Most of the data on the possible role ofrnetl~ylated 
nucleosides at the 5’-terminus of mRNAs comes from 
experiments in which activity of capped methylated 
mRNAs was compared with the activity of their 
unmodified or partially modified counterparts. There 
are several methods for obtaining such mRNA 
preparations: 
(1) The cores of some animal [4-81, insect [9,10] 
and plant viruses [I l] contain all the necessary 
enzymes for the in vitro synthesis of capped and 
methylated mRNAs. Viral core-directed mR.NA 
synthesis performed in the presence of the methyl 
donor, Ado&t, results in the production of mRNA 
molecules with a nl~GpppN~~~ terminus. Synthesis 
witl~out added AdoMet or in the presence of Ado&y, 
the inhibitor of methylation, produces mRNA ntole- 
cules with either ppN or GpppN at their 5’-ends 
[ 12-f 71. By further adjusting the reaction con- 
ditions a selective synthesis of mRNAs bearing 
either ppN or GpppN ends may be obtained as 
shown with reovirus cores [ 181. The vaccinia core- 
associated enzymes have also been used for the 
capping and 2’-O-methylation of RNAs which, as 
for instance STNV RNA [ 191, function noml~ly 
as uncapped molecules bearing (p)ppN at their 
5’-ends. 
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(2) The treatment of capped mRNA with periodate 
and aniline leads to the removal by P-elimination 
of the blocking m7G from the mRNA; the result- 
ing RNA has a pp~N(~) terminus [4,6,20]. It was 
pointed out that /%elimination may lead to some 
unspecific damage such as degradation or modifi- 
cation of the RNA [20] . In many instances this 
procedure was, however, applied successfully to 
functional studies [ 15,20-261 . 
(3) The nucleotide pyrophosphatase purified from 
tobacco cells [27,38] and potato (291 specifically 
cleaves the pyrophosphate linkages in the 5’- 
terminal cap of mRNA. Recently a very rapid 
procedure for the purification of tobacco cell 
enzyme has been described [30]. Phage T4-induced 
polynucleotide kinase was also reported to cleave 
the pyrophosphate bond from a cap structure 
[3 l] . However, the utility of this procedure needs 
to be confirmed [30]. 
(4) Synthetic ribopolymers of variable base composi- 
tion bearing different 5’-termini may be prepared 
by priming the polynucleotide phosphorylase- 
catalyzed reaction with m7GpppGmpC, GpppGpC 
or ppGpC [32] . 
3. The role of m’G in facilitating mRNA binding to 
ribosomes 
The initial observations that a 5’-terminal cap is 
required for efficient translation of mRNAs come 
from the comparison of activities of capped and 
uncapped reovirus, VSV and rabbit globin mRNAs 
in a wheat germ cell-free protein-synthesizing system 
[21,33] . Subsequently it was found that the 5’- 
terminal m’G is necessary for efficient binding of 
reovirus mRNAs to the 40 S ribosomal subunits during 
initiation of protein synthesis [ 121. A blocked and 
methylated 5’-terminus was required for the enhanced 
activity of reovirus mRNAs. Molecules with GpppN 
at their 5’-end were translated with low efficiency, as 
were (p)ppN-terminated mRNAs [ 12,24,34] . 
Further studies on the comparison of capped 
versus uncapped mRNA molecules have demonstrated 
the importance of the 5’-terminal m7G for in vitro 
translation of mRNAs of viruses such as reo [ 12,21, 
24,26,29,34-361 , VSV [ 14,15,20,24] , vaccinia 
2 
[25,37,38], CPV [28], BMV [23], TMV [X.39] 
and of cellular messengers like globin mRNA [21,36, 
28,29,39] , bovine parathyroid hormone mRNA [23] , 
ovalbumin mRNA [40] and Artemia salina mRNA 
[29,41]. Most of these studies were performed in a 
wheat germ protein-synthesizing system [ 13,15, 
21-25,28,39,33-35,37,39.41] The other cell-free 
systems used included the rabbit reticulocyte lysate 
[15,20,24,25,37-391 , Artemia salina extract [41] , 
mouse ascites cell extract [ 14,401 and a fractionated 
mammalian system of mixed origin [26,36] . 
An independent approach used to determine the 
importance of the 5’-terminal cap in translation 
involves the use of m7G cap analogs. Compounds 
such as pm7G, m7GDP, m7GpppN(m) but not their 
unmethylated counterparts are specific inhibitors of 
translation of capped mRNAs [42-471. The cap 
analogs act at the level of initiation by inhibiting 
mRNA binding to ribosomes [45%47] . Their inhibi- 
tory effect on the translation or binding to ribosomes 
of variety of capped mRNAs is documented in wheat 
germ [15,26,28,35,42-45,47-501 , Artemia salina 
[44] , L cell [45] , HeLa cell [5 l] , mouse ascites cell 
[40] and rabbit reticulocyte [38,39,46,48,52] 
extracts as well as in the fractionated mammalian 
system [26,36] . 
More recently evidence has been accumulated that, 
apart from inhibiting the initiation of capped mRNAs, 
cap analogs may also, although to lesser extent, 
interfere with translation of uncapped messengers 
[15,45,53,54]. This can be regarded as an indication 
that the same cellular component, possibly an initia- 
tion factor, involved in interaction with the 5’- 
terminus of capped mRNAs (see following sections), 
participates also in translation ofuncapped messengers. 
Cap analogs, when bound to a presumptive m7G- 
binding site of a factor, might indirectly affect the 
properties of its other site involved in recognition of 
an internal sequence in mRNA [ 53,551. 
Much evidence exists that the 5’-terminal m7G is 
not absolutely required for mRNA translation but 
plays rather a facilitating role in mRNA binding to 
ribosomes [ 15,20.22,24,26,37,56] All mRNAs which 
physiologically function as capped molecules and 
which have been studied so far may be translated 
in vitro into the authentic polypeptides also in the 
decapped or unmethylated form [ 15,20,22,26,29,35, 
37,391. Furthermore, the RNAs of picornaviruses 
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[58-631 , Feline Leukemia Virus* [63] and plant 
viruses like STNV [ 19,651 , Cow Pea Mosaic Virus 
[66] or Tobacco Necrosis Virus [67] are not capped, 
yet most of them act as efficient templates for 
protein synthesis [57,68-701. Moreover, the 
unmethylated messengers of prokaryotic origin which 
do not contain caps can be translated in eukaryotic 
cell-free systems, albeit less efficiently [71-751 . 
The presence of a m’G at the 5’-terminus of 
mRNAs increases primarily the rate and frequently 
also the extent of messenger binding to ribosomes 
in vitro. The ribosomal binding of capped and uncapped 
mRNAs of reovirus [24] , VSV [ 15,20,24] and 
vaccinia virus [25,37] was extensively studied in the 
wheat germ and rabbit reticulocyte cell-free systems. 
In all instances the absence of the m’G cap led to a 
pronounced decrease of both the rate and the extent 
of RNA binding. The readdition of m7G, but not of 
the unmethylated G, to the 5’-terminus of vaccinia 
virus mRNA subjected previously to &elimination 
resulted in the recovery of the translational activity 
of this mRNA [25] . 
Strong support for the facilitating role of m’G 
comes from experiments in which the activity of 
capped and uncapped ribopolymers was compared 
[24,32,76]. Polymers rich in A and U bind to wheat 
germ or rabbit reticulocyte ribosomes even in the 
absence of a modified 5’-terminus. Addition of 
m7GpppGm (but not of GpppG or ppG) to their 
5’-end, however increases the extent of polymer 
binding by -3-fold; the rate of binding is also 
markedly enhanced. Certain types of polymers are 
not able to bind to 80 S ribosomes but interact with 
the 40 S subunits. This interaction is also strongly 
promoted by the presence of m7GpppGm at the 
5’-end [24,32,76] . 
Further support in favor of a facilitating role of 
m’G in mRNA translation is provided by the results 
of competition experiments. When a mixture of 
capped and uncapped mRNA molecules is assayed 
* Although the 28 S RNA from the virions of Feline 
Leukemia Virus (FeLV-Rickard strain) is not capped, the 
virus-related mRNAs present in infected cells are capped 
[64]. There are indications that the 28 S RNA does not 
function as mRNA but corresponds rather to defective 
RNA molecules and not to the full-length FeLV genome 
[641 
for the ability to bind to ribosomes, those molecules 
which bear the m’G cap at their 5’-end are preferen- 
tially bound [24,25]. Such selection by ribosomes 
of capped over uncapped RNA molecules has been 
documented for reo [24] and vaccinia [25] virus 
mRNAs studied in a wheat germ extract and a rabbit 
reticulocyte lysate, respectively. The preferential 
translation of capped globin and reoviral mRNAs 
has also been demonstrated by competition experi- 
ments performed with a fractionated mammalian 
cell-free system [26] . 
A similar selection of capped over uncapped 
mRNA molecules most likely occurs also in vivo. In 
VSV-infected cells all polysome-associated viral 
mRNA is capped, whereas among cytoplasmic RNAs 
not bound to ribosomes there is a fraction of viral 
RNA with uncapped 5’-termini [77] . The translational 
activity of rabbit globin mRNAs subjected to periodate 
oxidation or p-elimination is diminished by -lo-fold 
in microinjectedXenopus Zuevis oocytes (R. E. Lockard 
and C. D. Lane, personal communication). 
Although the presence of a blocking m’G seems to 
facilitate translation of capped mRNAs, addition of 
7-methylguanosine to the 5’-end of STNV RNA, an 
mRNA which normally functions without cap, may 
not have a similar effect. Smith and Clark [78] have 
found that capped STNV RNA does not show an 
enhanced rate or extent of initiation of protein syn- 
thesis in vitro as compared to uncapped STNV RNA. 
However, in the binding of fragmented STNV RNAs 
to ribosomes, a capped preparation showed better 
messenger properties than uncapped STNV RNA, 
indicating that the tertiary structure of STNV RNA 
may preclude the functioning of the cap in this RNA 
molecule [57,78] . 
The apparent importance of the 5’-terminal m’G 
for translation of mRNAs is strongly influenced by 
the conditions of in vitro protein synthesis. Among 
the factors affecting the requirement for m’G are: 
the concentration of mRNA [22,35,39,42] and 
initiation factors [26,55] and the ionic conditions 
[37,39,48,54] or temperature [48] used for in vitro 
translation. Of particular importance is the potassium 
ion concentration. At low K’ (40-80 mM) little or 
no dependence on m’G is found; at higher K+ 
(-150 mM), which more closely resembles the cel- 
lular concentration [79] , m’G at the 5’-terminus 
stimulatesmRNA translation several fold [37,39,48,54]. 
3 
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The relation of K’ concentration to the observed 
requirement for m7G partially explains previous 
reports that translation in a reticulocyte lysate 
depends much less on m7G than that in a wheat germ 
extract [ 15,20,24] . When translation in these two 
systems is studied at similar K’ concentrations, the 
dependence onm7G becomes comparable [37,39,48]. 
Likewise, translation of endogenous globin mRNA in 
a reticulocyte lysate, which had been reported to be 
relatively resistant to inhibition by m7G analogs 
[15,46,52,80], depends on the presence of the m7G 
cap as does exogenous globin mRNA, provided the 
experiments are carried out at comparable K’ con- 
centrations [39,48] . The mechanism of K’-dependent 
differences in requirement for m7G is unknown. 
Translation in vitro at subsaturating levels of 
mRNA depends on m7G more strongly than at higher 
RNA concentrations [22,35,39,42]. Related to this 
are the observations that protection of the m7G cap- 
containing sequence within a 40 S initiation complex 
is higher at low mRNA concentrations in a wheat 
germ extract [81] . On the other hand, the require- 
ment for the m7G cap decreases when the concentra- 
tion of reticulocyte initiation factors is raised in a 
fractionated cell-free system [26,55] . It is conceivable 
that high mRNA and initiation factor concentrations 
increase the rate of initiation complex formation to 
such an extent that a facilitative role of the m7G cap 
is no longer strongly apparent. 
There are indications that translation of certain 
capped mRNAs may depend on the presence of m7G 
more than that of other messengers. P-Elimination 
decreases the ribosome binding activity of reovirus 
mRNA more than that of VSV mRNA [34] . Similar- 
ly, the m7G cap analogs inhibit translation of rabbit 
c@obin mRNA more strongly than translation of 
@lobin messenger [48,52]. The relative importance 
of m7G for translation of a given mRNA might depend 
on how efficiently an mRNA species is able to inter- 
act with ribosomes through structural features other 
than the 5’-terminal cap [20,24,82] . Further studies 
are required to answer this question. 
4. m7G and the ribosomal binding sites in mRNA 
Much information about the possible role of the 
5’-terminal m7G in eukaryotic protein synthesis 
comes from the analysis of mRNA sequences protected 
4 
by the ribosome during initiation of translation. 
Particularly extensively studied are the ribosomal 
binding sites of the 10 different species of reovirus 
mRNAs [56,81,X3-86] ; the binding sites of 6 of 
them have been sequenced [81,84-861. In the case 
of all reovirus mRNAs, the m7G cap constitutes a 
part of the nucleotide sequence protected within the 
40 S initiation complex formed in a wheat germ 
extract [81.83-851 . The length of the 40 S-protected, 
nuclease-resistant sequences varies, depending on the 
mRNA species, from 30 to about 60 nucleotides; all 
the fragments also contain the AUG codon located 
15-33 nucleotides away from 5’-terminal 7-methyl- 
guanosine [81,83-851. 
Fragments protected within the 80 S initiation 
complexes are substantially shorter, 35-29 nucleo- 
tides in length, with the AUG codon positioned 
centrally, 12-14 nucleotides away from the 5’-end 
of the fragment. For each individual reovirus mRNA, 
the fragment protected by the 80 S wheat germ ribo- 
some is the subset of a longer 40 S-protected sequence 
[81,83-851 . Similar differences in the lengths of 
40 S and 80 S-protected fragments were also observed 
with reticulocyte ribosomes for fl-globin [87] and reo- 
virus mRNAs [86]. In most instances the 80 S- 
protected fragments do not include the 5’-terminal 
cap [8 1,84-86,881 . 80 S ribosomes protect the cap 
only in those mRNAs m which the distance between 
the 5’-terminal m7G and the AUG codon is not longer 
than -15 nucleotides, as documented for two of the 
VSV mRNAs [88] and one of the reovirus mRNAs 
P51. 
The 40 S-protected capped fragments of reovirus 
mRNAs are able to rebind to wheat germ ribosomes 
much more efficiently than their uncapped 80 S- 
protected counterparts [56,83]. Efficient rebinding 
of the isolated 40 S-protected fragments indicates 
that they possess all the necessary features required 
for ribosome attachment. Different subfragments 
obtained by limited Tl RNase digestion of the 40 S- 
protected sequences were further analysed for their 
ability to rebind to ribosomes. Binding of the frag- 
ment was substantially reduced by removal of the 
5’-terminal region containing the m7G. When the 
AUG codon was missing the stable complex forma- 
tion with ribosomes was abolished completely, 
irrespective of the presence or absence of the m7G 
cap [56] . 
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The comparison of the known .5’-terminal sequences 
of different mRNAs reveals that the only common 
features of all these messengers include the presence 
of a 5’-terminal cap and of an AUG initiation codon 
positioned lo-69 nucleotides away from the 5’- 
terminus of the RNA [81,84-86,88-941. Moreover, 
it has not yet been established whether an mRNA- 
rRNA interaction, similar to that involving base 
pairing between the 3’-end of 16 S rRNA and the 
ribosomal binding sites of prokaryotic messengers 
[95,96] occurs also during initiation in eukaryotic 
systems. Most of the eukaryotic mRNAs appear to 
contain in the vicinity of the initiator AUG codon 
sequences that are complementary to the 18 S RNA 
(discussed in [97] ). However, contrary to the situa- 
tion with bacterial mRNAs, in the case of eukaryotic 
messengers the distance between the postulated com- 
plementary regions and the initiation codon is highly 
variable, thus weakening arguments for significant 
mRNA-rRNA interactions in eukaryotic initiation 
[85,97]. 
Based on all these data Kozak and Shatkin 
[56,81,85] suggest hat binding of ribosomes to 
eukaryotic mRNA may not involve the recognition 
of a specific nucleotide sequence in the mRNA. 
Instead, they propose that the presence of an AUG 
codon proximal to the 5’-terminus of the mRNA is 
of primary importance for the occurrence of an 
initiation event. Recent experiments involving the use 
of the antibiotic edeine in a wheat germ extract 
indicate that the 40 S ribosomal subunits may initially 
bind to the capped 5’-terminus of mRNA and sub- 
sequently move along the mRNA chain until they 
encounter the first AUG codon [98]. At that point 
joining of the 60 S subunit would complete the initia- 
tion event. Such a mechanism may explain why in 
numerous eukaryotic messengers with known 5’- 
terminal sequences protein synthesis starts at the 
AUG triplet located most closely to the S’end 
[81,84-86,88-941 . Displacement of the 40 S sub- 
unit from the 5’-end towards the AUG initiator 
codon would also explain why in messengers in which 
the AUG triplet is positioned relatively far from the 
5’-terminus the cap is not protected against ribo- 
nuclease by the 40 S subunit. No cap protection by 
the 40 S ribosomal subunit was observed for rabbit 
P-globin mRNA [86,87] and TMV RNA ([98] , 
W. F. and A. L. Haenni. unpublished results) having 
the AUG codons 54 and 69 nucleotides away from 
the 5’-terminus, respectively [90,93]. 
The possible role of the terminal m7G in eukaryotic 
initiation would be to facilitate initial binding of the 
40 S subunit to the 5’-end of mRNA. As recently 
suggested [56] the m7G might promote, possibly by 
interacting with specific protein(s), a loosening of 
mRNA conformation at its 5’-end. This suggestion is 
based on the finding that after mild formaldehyde 
treatment the unmethylated reovirus mRNA becomes 
able to bind to wheat germ ribosomes and that the 
uncapped 5’-terminal fragments but not the full-length 
unmethylated reovirus mRNA, show a low level of 
binding to ribosomes [56] . Decreased dependence 
of mRNA translation on the m7G cap at low K’ 
[37,39,48] or at high temperatures [48] , which 
conditions possibly also favor a less compact RNA 
structure, further supports this possibility. 
The same AUG codon would, however, be selected 
by the 40 S subunit irrespective of the presence or 
absence of the terminal 7-methylguanosine. This was 
directly determined by fingerprint analysis of the 
ribosome-protected fragments originating from 
capped and uncapped reovirus mRNAs [56] ; the 
same sites are protected also by reticulocyte ribosomes 
in capped and uncapped VSV mRNAs [88]. Hence, 
the effect of the m7G cap on mRNA binding would 
be quantitative rather than qualitative. The possibility 
of translating uncapped messengers into authentic 
polypeptide products supports this notion [ 15,20,22, 
26,29,35,37-391. Interestingly, Rose [88] has noted 
that in the case of uncapped VSV mRNAs the ribo- 
somes apart from recognizing the proper initiation 
sites also interact at low efficiency with many non- 
initiating nucleotide sequences in the mRNA. This 
result might suggest hat the cap at the 5’-terminus 
helps to restrict the initiation events to the AUG 
codon located most closely to the 5’-terminus of 
mRNA. Since it appears that eukaryotic ribosomes 
are able to initiate translation with Q/3 and R17 RNAs 
[71-741 or bacteriophage fl mRNA [97a] internally, 
it would be of interest to know whether the addition 
of m7G cap to such RNA molecules affects their 
translation in vitro in a eukaryotic system. 
5. Proteins binding to the m7G cap 
Several protein initiation factors have been isolated 
5 
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which are required for binding of natural mRNAs to polypeptide binds to the 5’-terminal cap of mRNA 
40 S initiation complexes [99-1011. It is conceivable [ 1041. The presence of the 74 000 mol. wt poly- 
that one or more of these proteins may be involved in peptide in eIF-4B preparations explains perhaps 
recognition of the methylated 5’-terminus of the partially the previous findings that eIF4B binds to the 
mRNA. m7G cap in mRNA [46] 
A protein that specifically binds the methylated 
oligonucleotide m7GpppCpC was identified in a high 
salt wash of Artenziu salirza ribosomes [44] . As 
indicated by competition assays, this protein also 
forms a complex with capped mRNAs. The Ammiu 
protein apparently does not corrcspond to one of the 
known initiation factors from rabbit reticulocytes 
since these factors do not form a stable complex with 
m7GpppGpC [44]. 
Other studies mdicate however that one or more 
of the known initiation factors may be involved in 
m7G cap recognition. A preparation of SO-90% pure 
reticulocyte initiation factor eIF4B (mol. wt 80 000) 
binds to capped histone or VSV mRNAs and this 
binding is specifically inhibited by the pm7G analog 
[46]. The same factor binds also to uncapped EMC 
RNA but this interaction is not prevented by pm’G. 
Hence, it is likely that eIF-4B recognizes the 5’- 
terminus as well as another sequence in mRNA [46]. 
eIF-4B is indeed required for translation of both 
capped and uncapped mRNAs [99,102]. 
In their recent work, Kaempfer et al. [55] present 
evidence that the initiation factor eIF-2, which forms 
a ternary complex with initiator Met-tRNAr and GTP, 
also binds the mRNA. It is proposed that apart from 
the site for Met-tRNA, binding, eIF-2 also has two 
mRNA binding sites, one of them involved in m7G 
cap recognition. Attempts to identify specific sites 
within rabbit globin mRNA based on protection by 
eIF-2 against rrbonuclease digestion were however 
unsuccessful m that random protection of mRNA 
sequences was obtained (H. Robertson and T. Hunt, 
personal communication). 
It is difficult at this moment to reconcile these 
somewhat conflicting reports on the involvement of 
protein factors in m7G cap recognition. Possibly more 
than one factor is Involved. Moreover, the positioning 
of the 5’-end of mRNA within the initiation complex 
may differ at various stages of complex assembly. 
6. The structural requirement for m7G cap recognition 
Proteins that are located adjacent to the 5’-terminal 
m7G within the initiation complex have been identi- 
fied by chemical crosslinking. In a wheat germ 
extract three polypeptides of mol. wt 135 000. 
93 000 and 26 000 and in a reticulocyte lysate two 
polypeptides ofmol. wt 160 000 and 35 000 crosslink 
to the periodate oxidized 5’-terminus of reovirus 
mRNA [ 1031 . Crosslinking of all proteins depends on 
the formation of an initiation complex; it is inhibited 
by cap analogs or AMPP(NH)P which decrease the 
yield of mRNA binding to ribosomes [ 1031 . The 
polypcptide of mol. wt 160 000 may correspond to 
the 160 000 mol. wt subunit of the multicomponent 
initiation factor cIF-3; this factor is necessary for 
mRNA binding to ribosomes [99-1011. 
The purified rabbit reticulocytc and mouse ascites 
initiation factors were also assayed for their ability to 
interact with the 5’-terminal cap of reovirus mRNA by 
a chemical crosshnking method. Crosslinking of a 
24 000 mol. wt polypeptide, present mainly in eIF-3 
and to a lesser extent in eIF-4B preparatrons, was 
inhibited by the m7GDP analog. indicating that this 
Studies with the different cap analogs have helped 
to gain some insight in the structural requirements 
for cap recognition during the assembly of the initia- 
tion complex. The minimal requirement for guanosine 
analogs to act as inhibitors of capped mRNA transla- 
tion is the presence of the 7-methyl and 5’-phosphate 
groups; 7methylguanosine. guanosine-5’-phosphate 
or 7-methylguanosine-2’,3’-phosphate do not inhibit 
translation [42,45,47] 7-Methylguanosine-5’- 
diphosphate is more mhibitory than the mono- 
phosphate counterpart, while m7GTP, m’GpppN or 
m7GpppNm show identical inhibitory activity to 
m7GDP [43,44] . Nuclear magnetic resonance analysis 
indicates that 7methylated 5’-phosphorylated 
guanosine may assume a defined rigid conformation 
because of the electrostatic interaction between the 
positively-charged imidazole moiety and the negatively- 
charged phosphate group. This conformation is more 
strongly favored in m7GDP than in pm7G, further 
phosphate addition being without effect [43,105] . 
7-Ethyl- and 7-benzyl-GDP are as active in inhibi- 
6 
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tion of reovirus mRNA binding to ribosomes as 
m’GDP. Hence, it is not the nature of the substituent 
but rather a positive charge resulting from 7-alkylation 
which is required for inhibitory activity of the analog 
[106]. The data on the activity of other m7GDP- 
related compounds also speak in favor of the impor- 
tance of a positive charge on the imidazole ring and 
its involvement in interaction with the phosphate 
group [ 1061. The cap structure within the mRNA 
may have a conformation similar to that of the m7G 
cap analogs. By replacing AdoMet by its analog, 
~-adenosylethionin~, Furuichi and Shatkin [ 1071 
have synthesized in vitro reovirus mRNAs bearing 
7-ethylguanosine at the 5’-termini. The ethylated 
mRNAs bind to ribosomes to the same extent as 
methylated mRNAs and are translated in vitro into 
authentic reovirus polypeptides ]107]. 
The 3-amino group of m’GDP is also important 
for inhibitory activity, since 7-methylinosine phos- 
phates are less inhibitory than m’G analogs [43,106] 
and 7-methylxanthosine-5’-diphosphate is inactive 
[ 1061 . Moreover, since 1 ,i’-dimethyl-GDP and 
6-Cl-m7GDP are also inactive as inllibitors, it is con- 
ceivable that during assembly of the initiation com- 
plex the N-l and N* atoms of m7G are used for 
hydrogen bond formation with an as yet unidentified 
cellular component [ 1061 . 
7. m’G and mRNA stabihty 
The cap structures at the 5’-end of mRNA have an 
important stabilizing effect on mRNA injected into 
Xetlopus Iaevis oocytes or added to wheat germ or 
L cell protein synthesizing extracts ]34] . In all these 
three systems reovirus mRNAs containing m7GpppGm 
or GpppG at their 5’-termini are degraded more 
slowly than molecules bearing pppGm, pppG or ppG 
ends. Degradation kinetics of molecules containing 
rl17GpppGm or GpppG termini are identical indicating 
that blocking of the ?-end with guanosine, without 
methylation, is sufficient for protection of the RNA 
against nucleases. Since the same GpppG-terminated 
molecules are not active as messengers in vitro it 
seems that protection of the RNA is not a conse- 
quence of its participation in protein synthesis, but 
rather an intrinsic property of RNAs with blocked 
5’-termini [34]. Similar preferential degradation of 
uncapped RNA molecules by a wheat germ extract 
was also established for CPV mRNA [28] . 
The unblocked mRNAs are most likely degraded 
in a 5’-+3’ direction exonucleolytically since the 
primary products of RNA hydrolysis appear to be 
.5’-mononucleotides, and since almost no degradation 
products of intermediate size (poly- or oligonucleo- 
tides) are found [28,34]. Contrary to the three 
systems mentioned above the rabbit reticulocyte 
Iysate does not contain the nuclease(s) involved in 
the preferential degradation of unblocked reovirus 
mRNAs [34]. 
The presence of a terminal 7-methylguanosine is 
most likely not the only factor determining mRNA 
stability. Viral RNAs which do not contain the cap 
are nevertheless active messengers both in vitro and 
in vivo. Sinl~arly, the ellzymatically-decapped TMV 
RNA, but not decapped rabbit globin mRNA, seems to 
be a relatively stable RNA molecule, as inferred from 
its messenger activity in a wheat germ extract [39] . 
As already suggested [34] some of the uncapped 
RNA motecules may be protected against exonuclease 
degradation by interaction with proteins or by a 
specific conformation at their 5’-termini. 
8. Other possible functions of the modified S’end 
of mRNA 
Facilitation of mRNA binding to ribosomes and 
protection of RNA against nucleases seem to be 
relatively well established functions of the 7-methyl- 
guanosine that blocks the 5’-terminus of eukaryotic 
mRNAs. It is not excluded however that the 5’- 
terminal cap also plays some role during transcription 
or in mRNA processing and transport from the 
nucleus to the cytoplasm [ 1081 . 
Molecules of heterogenous nuclear RNA (HnRNA) 
also contain capped methylated 5’-termini and con- 
siderable evidence exists that, in many instances, caps 
present in HnRNA are conserved in the corresponding 
cytoplasmic mRNA molecules [ 109,l IO] , most 
likely as a consequence of the splicing events. The 
transfer of 5’-terminal precursor segments to the 
mature mRNA molecules may be considered as a 
further indication of the importance of the cap for 
mRNA translation or stability. 
Furuichi [ 11 I] has noted that the in vitro tran- 
7 
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scription of CPV depends on the presence of AdoMet. 
The requirement for AdoMet is however not due to 
its activity as a methyl donor since AdoHcy, an 
inhibitor of methylation, also stimulates synthesis of 
CPV mRNA. More likely AdoMet or related com- 
pounds act as allostcric effecters influencing the 
RNA polymerase and/or the capping enzymes [ 171 .
Some early events in cap formation are nevertheless 
required for CPV mRNA synthesis. This is supported 
by experiments in which it was shown that CPV RNA 
polymerase cannot initiate the transcription process 
when ATP, incorporated normally as the 5’-terminal 
nucleotide. is replaced by its /3,y-imido analog, 
AMPP(NH)P [ 171. Under physiological conditions, 
the first step during CPV mRNA cap formation most 
likely involves the removal of the y-phosphate from 
the 5’-terminal ATP, catalysed by a virion-associated 
nucleotlde phosphohydrolase. The fl,y-imido analog 
of ATP cannot be hydrolysed by the enzyme. Sur- 
prisingly, its presence prevents not only cap forma- 
tion but inhibits also the whole transcription process 
1171' 
A relation between methylation at the 5’-end and 
the polyadenylation at the 3’-end of mRNA was 
observed during in vitro transcription of VSV virions 
[ 1121 . The VSV mRNAs synthesized in the presence 
of AdoHcy in place of AdoMet contain abnormally 
large poly(A) segments, up to 2000 nucleotides in 
length. It is not known however whether the synthesis 
of long poly(A) tails is a genuine consequence of an 
inhibition of mRNA methylation or rather a direct 
result bf the presence of AdoHcy [ 1121. 
Unfertilized oocytes or dormant embryos of a 
variety of organisms contain latent maternal mRNAs; 
during the early stages of development the stored 
mRNAs become active templates for protein syn- 
thesis. The methylation of preexisting mRNAs could 
serve as a simple mechanism for ‘turning on’ protein 
synthesis. Indeed, it has been shown that mRNAs 
isolated from the unfertilized oocytes of the insect, 
tobacco hornworm, contain at their 5’-end the 
blocked, but unmethylated structure GpppN, suggest- 
mg that translational inactivity of mRNA prior to 
fertilization may be related to the absence of N7- 
methylation [ 1131. However, this does not seem to 
be a general phenomenon since direct or indirect 
evidence exists that ‘dormant’ mRNAs isolated from 
sea urchin and Xerzopus laevis oocytcs as well as from 
8 
dry cysts of Artemia saluza do contain the m7G 
caps at their 5’-termini [41 .114,115]. 
While much data has accumulated on possible 
functions of 5’-terminal 7-methylguanosine little is 
known about the role of the rlbose methylations 
present in the second and third nucleotides from the 
5’-end of many mRNAs. Moreover no function has as 
yet been ascribed to the methylated nucleosides. 
mainly 6-methyladenosine, occurring Internally in 
many mRNA species (reviewed in [3,1 lo] ). Studies 
of Muthukrishnan et al. [24,25,76] indicate that 
2’-O-methylation of the penultimate nucleoside may 
have a positive influence on mRNA binding to ribo- 
somes. Most of the evidence in favor of this possibility 
comes from experiments with synthetic polynucleo- 
tides bearing m7GpppGm or m7GpppG termini 
[24,76] . This stimulatory effect of 3’-0-methylation 
on polymer binding to ribosomes is particularly 
evident when ribopolymers with weak affinities for 
ribosomes are employed in binding experiments 
[24,76] . This may explain why only little or no 
preference for 2’-0-methylated mRNAs is observed 
when capped vaccinia virus mRNAs (which are rather 
strong ribosomal ‘binders’) bearing the m7GpppN or 
m7GpppNm termini are compared for their ability to 
bind to wheat germ or rabbit reticulocyte ribosomes 
[35] . Further studies are required in order to elucidate 
a function of the penultimate and internal mcthyla- 
tions in eukaryotic mRNAs. 
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